CN Patent

CN1901890B — 大体线性的泡腾口服芬太尼剂型和施用方法

Assigned to Cima Labs Inc · Expires 2012-03-14 · 14y expired

What this patent protects

本发明披露了含有芬太尼的剂型和使用该剂型的方法。与已知的口服制剂相比，这些剂型包括重量明显更少的芬太尼，并且在成本和副作用方面具有优势。所述剂型旨在经口施用芬太尼通过口腔粘膜。

USPTO Abstract

本发明披露了含有芬太尼的剂型和使用该剂型的方法。与已知的口服制剂相比，这些剂型包括重量明显更少的芬太尼，并且在成本和副作用方面具有优势。所述剂型旨在经口施用芬太尼通过口腔粘膜。

Drugs covered by this patent

apomorphine-hydrochloride (APOMORPHINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN1901890B
Jurisdiction: CN
Classification: —
Expires: 2012-03-14
Drug substance claim: No
Drug product claim: No
Assignee: Cima Labs Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.